Sign in
4

Changes in Ownership

Eloxx Pharmaceuticals, Inc. Filed Acc 0001209191-18-038660

Options or other derivatives

  • 10% owner acquired 80,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Pontifax Management 4 G.P. (2015) Ltd. · 10% owner

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2018-06-15 Grant or award : show line 1 in the form Stock Option (Right to Buy) +40,000 40,000 I
2018-06-15 Grant or award : show line 2 in the form Stock Option (Right to Buy) +40,000 40,000 I
Loading xslF345X03/doc4.xml…